Compound Detail
CHEMBL5483011
INDINAVIR 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O.O
24
Targets
240
Activities
4
Assay Types
30
PK Parameters
20
Publications
3
Known Names
4
Indications
Molecular Properties
613.8
MW (Da)
2.87
ALogP
7
HBA
4
HBD
118.0
PSA (Ų)
0.26
QED
1
Ro5 Violations
11
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Virus Diseases Acquired Immunodeficiency Syndrome HIV Infections Sarcoma, Kaposi
ATC Classification
J05AE02
indinavir
Level 1: ANTIINFECTIVES FOR SYSTEMIC USE
Level 2: ANTIVIRALS FOR SYSTEMIC USE
Activity Summary
IC50 119 meas. best 9.44
EC50 68 meas. best 10.3
Ki 48 meas. best 10.15
Kd 5 meas. best 8.97
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Human immunodeficiency virus 1 CHEMBL378 | EC50 | 10.3 | 7.0527 | 0.1 | 55 |
| Human immunodeficiency virus type 1 protease CHEMBL243 | Ki | 10.15 | 8.7182 | 0.1 | 28 |
| Protease CHEMBL2366517 | Ki | 9.92 | 9.2238 | 0.1 | 8 |
| Human immunodeficiency virus type 1 protease CHEMBL243 | IC50 | 9.44 | 8.2729 | 0.4 | 34 |
| HIV protease CHEMBL3638323 | Ki | 9.42 | 9.42 | 0.4 | 1 |
| Protease CHEMBL2366517 | IC50 | 9.4 | 9.2267 | 0.4 | 3 |
| Human immunodeficiency virus type 1 protease CHEMBL243 | Kd | 8.97 | 8.97 | 1.1 | 2 |
| Protease CHEMBL2366517 | Kd | 8.92 | 8.68 | 1.2 | 3 |
| Human rhinovirus A protease CHEMBL2857 | Ki | 8.48 | 8.48 | 3.3 | 1 |
| Human immunodeficiency virus 2 CHEMBL380 | IC50 | 8.4 | 6.6263 | 4.0 | 27 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 8.3 | 8.3 | 5.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 8.15 | 6.7438 | 7.0 | 8 |
| Human immunodeficiency virus 1 CHEMBL378 | IC50 | 7.85 | 7.2532 | 14.0 | 19 |
| Human immunodeficiency virus 2 CHEMBL380 | EC50 | 7.66 | 7.3956 | 22.0 | 9 |
| MT4 CHEMBL388 | IC50 | 7.4 | 6.8114 | 40.0 | 7 |
| Human immunodeficiency virus CHEMBL613758 | EC50 | 7.36 | 7.36 | 44.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 7.36 | 7.285 | 43.6 | 2 |
| Human immunodeficiency virus CHEMBL613758 | IC50 | 7.3 | 6.7133 | 50.0 | 3 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 6.82 | 6.736 | 150.0 | 5 |
| Cytochrome P450 3A4 CHEMBL340 | Ki | 6.32 | 6.32 | 480.0 | 1 |
| Multidrug and toxin extrusion protein 1 CHEMBL1743126 | IC50 | 5.77 | 5.5333 | 1700.0 | 3 |
| Substance-K receptor CHEMBL2327 | Ki | 5.77 | 5.77 | 1700.0 | 1 |
| Thromboxane-A synthase CHEMBL1835 | IC50 | 5.73 | 5.73 | 1851.0 | 1 |
| PBMC CHEMBL613107 | EC50 | 5.52 | 5.15 | 3000.0 | 2 |
| Plasmodium yoelii yoelii CHEMBL612328 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
| Substance-K receptor CHEMBL2327 | IC50 | 5.29 | 5.29 | 5101.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.22 | 5.22 | 6030.0 | 1 |
| Multidrug and toxin extrusion protein 2 CHEMBL1743127 | IC50 | 5.11 | 5.11 | 7800.0 | 1 |
| Bile salt export pump CHEMBL6020 | IC50 | 4.67 | 4.67 | 21200.0 | 3 |
| ATP-dependent translocase ABCB1 CHEMBL4302 | IC50 | 4.36 | 4.36 | 44000.0 | 1 |
| Trypanosoma brucei rhodesiense CHEMBL612348 | IC50 | 4.32 | 4.32 | 48190.0 | 1 |
| Solute carrier family 22 member 1 CHEMBL2073670 | IC50 | 4.21 | 4.21 | 61700.0 | 1 |
| ATP-binding cassette sub-family C member 3 CHEMBL5918 | IC50 | 4.08 | 4.08 | 83000.0 | 1 |
| Trypanosoma cruzi CHEMBL368 | IC50 | 4.03 | 4.03 | 93550.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 7672.5 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 7672.5 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 188.44 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 7672.5 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 7650.0 | ng.hr.mL-1 | Homo sapiens |
| AUC | 23816.67 | ng.hr.mL-1 | Homo sapiens |
| AUC | 27713.07 | ng.hr.mL-1 | Homo sapiens |
| CL | 50.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 16.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 49.5 | mL.min-1.kg-1 | Homo sapiens |
| CL | 50.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 18.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 18.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 10.23 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 53.7 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| Cmax | 11400.0 | nM | Canis lupus familiaris |
| Cmax | 11400.0 | nM | Canis lupus familiaris |
| Cmax | 358.0 | nM | Canis lupus familiaris |
| Cmax | 11400.0 | nM | Canis lupus familiaris |
| Cmax | 11400.0 | nM | Canis lupus familiaris |
| Cmax | 12000.0 | nM | - |
| Cmax | 11400.0 | nM | Canis lupus familiaris |
| Cmax | 7119.58 | nM | Homo sapiens |
| Cmax | 15102.64 | nM | Homo sapiens |
| Cmax | 11730.0 | nM | Homo sapiens |
| F | 72.0 | % | Canis lupus familiaris |
| F | 71.6 | % | Canis lupus familiaris |
| F | 90.0 | % | Canis lupus familiaris |
| F | 76.0 | % | Rattus norvegicus |
| Fu | 0.36 | - | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 261 |
| 17638694 | 10.1128/aac.00149-07 | Human immunodeficiency virus 1 | 53 |
| 18227188 | 10.1128/aac.01284-07 | Human immunodeficiency virus 2 | 36 |
| 17101675 | 10.1128/aac.00690-06 | Human immunodeficiency virus 1 | 33 |
| 18955518 | 10.1128/aac.00689-08 | Human immunodeficiency virus 1 | 33 |
| 17371811 | 10.1128/aac.01413-06 | Human immunodeficiency virus 1 | 24 |
| 16472241 | 10.2174/1570163043334794 | Hepatotoxicity | 18 |
| 17981045 | 10.1016/j.bmc.2007.10.062 | Human immunodeficiency virus 1 | 17 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 19746963 | 10.1021/jm900695w | Human immunodeficiency virus 1 | 13 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 16913714 | 10.1021/jm060561m | Human immunodeficiency virus 1 | 11 |
| 16298527 | 10.1016/j.bmcl.2005.11.011 | Human immunodeficiency virus 1 | 11 |
| 17158945 | 10.1128/aac.00420-06 | Homo sapiens | 10 |
| 17576848 | 10.1128/aac.00146-07 | Human immunodeficiency virus 2 | 10 |
| 21051535 | 10.1124/dmd.110.034629 | ADMET | 9 |
| 18212102 | 10.1128/aac.01132-07 | Human immunodeficiency virus 1 | 9 |
| 19473017 | 10.1021/jm900303m | Human immunodeficiency virus 1 | 9 |
| 17116674 | 10.1128/aac.00870-06 | Human immunodeficiency virus 2 | 9 |
| 18783203 | 10.1021/jm8004543 | Human immunodeficiency virus 1 | 8 |
Data from ChEMBL 36 via Core Engine